Skip to Main content Skip to Navigation

Roles of ERK1/2 signaling in LMNA-cardiomyopathy

Abstract : Dilated cardiomyopathy is one of the leading causes of heart failure in Europe. Despite of the conventional medical care, there is no definitive treatment for the progressive cardiac dilatation and loss of contractility in LMNA cardiomyopathy often leading to sudden death or heart transplantation. LMNA gene encodes nuclear A-type lamins, which are the main constituents of the nuclear lamina. Previous studies clearly show that the abnormal ERK1/2 activation is involved in the pathophysiology of LMNA dilated cardiomyopathy. However, its role in the development of cardiac dysfunction remains unclear. Inhibition of ERK1/2 signaling also slows progression of myocardial fibrosis, which is prominent in humans with dilated cardiomyopathy. I suggested that aberrant TGF-β signaling activity could participate to the abnormal ERK1/2 activation and be involved is the pathophysiology of left-ventricular contractile dysfunction in LMNA cardiomyopathy. Given that the understanding of molecular and cellular mechanisms underlying the modulation of ERK1/2 signaling in the heart caused by LMNA mutation remains totally unclear, I tested the hypothesis that ERK1/2 abnormal modulation leads to alteration of cytosolic targets and alter cardiac cytoskeleton network. My work highlighted a novel partner of activated (phosphorylated) ERK1/2, ADF/cofilin-1. Cofilin promotes debranching of actin filaments. I showed that disrupted actin dynamics leads to abnormal sarcomere structure. This project unraveled an unexpected role played by ERK1/2 signaling in actin dynamics and in the development of left-ventricular dysfunction in LMNA cardiomyopathy.
Complete list of metadatas

Cited literature [631 references]  Display  Hide  Download
Contributor : Abes Star :  Contact
Submitted on : Saturday, November 10, 2018 - 1:01:32 AM
Last modification on : Sunday, October 25, 2020 - 6:23:34 PM
Long-term archiving on: : Monday, February 11, 2019 - 12:30:59 PM


Version validated by the jury (STAR)


  • HAL Id : tel-01918182, version 1


Maria Chatzifrangkeskou. Roles of ERK1/2 signaling in LMNA-cardiomyopathy. Cardiology and cardiovascular system. Université Pierre et Marie Curie - Paris VI; Freie Universität (Berlin), 2016. English. ⟨NNT : 2016PA066380⟩. ⟨tel-01918182⟩



Record views


Files downloads